Aigen Investment Management, LP Amgen Inc Transaction History

Aigen Investment Management, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$262.75 - $319.31 $304,790 - $370,399	1,160 New	1,160 $362,000
Q2 2022 Aug 02, 2022	BUY	$230.71 - $256.74 $3.6 Million - $4.01 Million	15,614 New	15,614 $3.8 Million
Q1 2022 May 05, 2022	SELL	$219.27 - $242.57 $601,457 - $665,369	-2,743 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $545,527 - $624,306	2,743 New	2,743 $582,000
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $274,456 - $304,489	-1,175 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $4.17 Million - $4.86 Million	-18,797 Reduced 94.12%	1,175 $292,000
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $4.32 Million - $5.15 Million	19,972 New	19,972 $4.59 Million
Q2 2020 Aug 10, 2020	SELL	$197.81 - $242.74 $2 Million - $2.45 Million	-10,087 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$182.24 - $241.7 $946,554 - $1.26 Million	5,194 Added 106.15%	10,087 $2.05 Million
Q4 2019 Feb 04, 2020	BUY	$189.21 - $243.2 $925,804 - $1.19 Million	4,893 New	4,893 $1.18 Million

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.